Document Detail


Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors.
MedLine Citation:
PMID:  19122059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of adjuvant 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; lomustine) to treat incompletely excised canine mast cell tumors (MCTs) has not been evaluated. Medical records of 12 dogs with grade 2 MCT treated with incomplete surgical excision and adjuvant CCNU and prednisone chemotherapy were reviewed. Local recurrence rate, metastasis rate, and survival time were evaluated. None of the dogs developed local recurrence or regional/ distant metastases. Two dogs developed fatal liver failure. The 1- and 2-year progression-free rates of surviving dogs were 100% and 77%, respectively. Postoperative adjuvant CCNU appears to be a useful alternative to radiation therapy for incompletely excised canine cutaneous MCTs.
Authors:
Kenji Hosoya; William C Kisseberth; Francisco J Alvarez; Ana Lara-Garcia; Gillian Beamer; Paul C Stromberg; C Guillermo Couto
Related Documents :
15070059 - Liposarcomas in dogs: 56 cases (1989-2000).
15448009 - Prognostic significance of tp53 tumor suppressor gene expression and mutations in human...
3583889 - Surgical treatment of epulides in dogs: 25 cases (1974-1984).
16795069 - Primary versus radiation-associated craniofacial osteosarcoma: biologic and clinicopath...
17189419 - Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-i pep...
18683209 - An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdiv...
10949399 - Malignant melanoma of the vagina. a report of 15 cases.
17545799 - Second line therapies for the treatment of gastrointestinal stromal tumor.
15911929 - Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumor...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Animal Hospital Association     Volume:  45     ISSN:  1547-3317     ISO Abbreviation:  J Am Anim Hosp Assoc     Publication Date:    2009 Jan-Feb
Date Detail:
Created Date:  2009-01-05     Completed Date:  2009-03-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0415027     Medline TA:  J Am Anim Hosp Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  14-8     Citation Subset:  IM    
Affiliation:
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, Ohio 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents, Alkylating / adverse effects,  therapeutic use*
Antineoplastic Agents, Hormonal / therapeutic use*
Dog Diseases / drug therapy*,  surgery
Dogs
Drug Therapy, Combination
Female
Liver Failure / etiology,  veterinary
Lomustine / adverse effects,  therapeutic use*
Male
Mast-Cell Sarcoma / drug therapy,  surgery,  veterinary*
Prednisone / therapeutic use*
Retrospective Studies
Survival Analysis
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 0/Antineoplastic Agents, Hormonal; 13010-47-4/Lomustine; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluations of labrador retrievers with exercise-induced collapse, including response to a standardi...
Next Document:  Effects of carprofen and morphine on the minimum alveolar concentration of isoflurane in dogs.